Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2001
Interleukin 8 is an autocrine growth factor and a surrogate marker for Kaposi's sarcomaR Masood, J Cai, A Tulpule, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Interleukin-4 in the treatment of AIDS-related Kaposi's sarcomaA Tulpule, B Joshi, N DeGuzman, et al.Current Opinion in Oncology|November 4, 1998
Emerging treatments for epidemic (AIDS-related) Kaposi's sarcomaM E McGarvey, A Tulpule, J Cai, et al.Cancer|August 1, 1996
Low dose methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine, and dexamethasone with zalcitabine in patients with acquired immunodeficiency syndrome-related lymphoma. Effect on human immunodeficiency virus and serum interleukin-6 levels over timeA M Levine, A Tulpule, B Espina, et al.Investigational New Drugs|January 1, 1994
Intraperitoneal 5-fluoro-2'-deoxyuridine with escalating doses of leucovorin: pharmacology and clinical toleranceF M Muggia, A Tulpule, A Retzios, et al.Cancer|December 5, 1998
Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphomaA Tulpule, G Schiller, L A Harvey-Buchanan, et al.The Journal of Biological Chemistry|December 15, 1988
Altered regulation of P-450IA1 expression in a multidrug-resistant MCF-7 human breast cancer cell lineS P Ivy, A Tulpule, C R Fairchild, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcomaA Tulpule, R C Yung, J Wernz, et al.Cancer Chemotherapy and Pharmacology|January 1, 1995
Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity studyV K Israel, C Jiang, F M Muggia, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicinP S Gill, B M Espina, F Muggia, et al.Pageof 4